help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sammarco, I.
Right arrow Articles by Geremia, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sammarco, I.
Right arrow Articles by Geremia, R.
The Journal of Clinical Endocrinology & Metabolism Vol. 85, No. 9 3256-3261
Copyright © 2000 by The Endocrine Society


Original Studies

Novel Point Mutation in the Splice Donor Site of Exon-Intron Junction 6 of the Androgen Receptor Gene in a Patient with Partial Androgen Insensitivity Syndrome1

Innocenzo Sammarco, Paola Grimaldi, Pellegrino Rossi, Marco Cappa, Costanzo Moretti, Gaetano Frajese and Raffaele Geremia

Department of Public Health and Cell Biology, Section of Anatomy (I.S., P.G., P.R., R.G.), University of Tor Vergata, 00133 Rome; Research and Cure Scientific Institute, Bambino Gesù, Unit of Auxology (M.C.), 00050 Palidoro; and Department of Internal Medicine, Section of Endocrinology (C.M., G.F.), University of Tor Vergata, 00133 Rome, Italy

Address all correspondence and requests for reprints to: Prof. Geremia Raffaele, Dipartimento di Sanita Pubblica e Biologia Cellulare, Sezione di Anatomia Umana, Via di Tor Vergata, 00133 Rome, Italy. E-mail: geremia{at}uniroma2.it

Androgen receptor (AR) gene mutations have been shown to cause androgen insensitivity syndrome with altered sexual differentiation in XY individuals, ranging from a partial insensitivity with male phenotype and azoospermia to a complete insensitivity with female phenotype and the absence of pubic and axillary sexual hair after puberty.

In this study we present an 11-yr-old XY girl, with clinical manifestations peculiar for impaired androgen biological action, including female phenotype, blind-ending vagina, small degree of posterior labial fusion, and absence of uterus, fallopian tubes, and ovaries. At the time of the diagnosis the patient had a FSH/LH ratio according to the puberal stage, undetectable 17ß-estradiol, and high levels of testosterone (80.1 ng/mL). After bilateral gonadectomy, performed at the age of 11 yr, histological examination showed small embryonic seminiferous tubules containing prevalently Sertoli cells and occasional spermatogonia together with abundant fibrous tissue. Molecular study of the patient showed a guanine to thymine transversion in position +5 of the donor splice site in the junction between exon 6 and intron 6 of the AR gene. The result of RT-PCR amplification of the AR messenger ribonucleic acid from cultured genital skin fibroblasts of the patient suggests that splicing is defective, and intron 6 is retained in most of the receptor messenger ribonucleic acid molecules. We show by immunoblotting that most of the expressed protein lacks part of the C-terminal hormone-binding domain, and a small amount of normal receptor is observed. This is probably responsible for the reduced binding capacity in genital skin fibroblasts of the patient.

The molecular basis of the alteration in this case is a novel, uncommon mutation, leading to a phenotype indicative of a partial androgen insensitivity syndrome, Quigley’s grade 5.




This article has been cited by other articles:


Home page
EndocrinologyHome page
M. Jagla, M. Feve, P. Kessler, G. Lapouge, E. Erdmann, S. Serra, J.-P. Bergerat, and J. Ceraline
A Splicing Variant of the Androgen Receptor Detected in a Metastatic Prostate Cancer Exhibits Exclusively Cytoplasmic Actions
Endocrinology, September 1, 2007; 148(9): 4334 - 4343.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
T. Chen, C. R. Jackson, A. Link, M. P. Markey, B. M. Colligan, L. E. Douglass, J. O. Pemberton, J. A. Deddens, J. R. Graff, and J. H. Carter
Int7G24A Variant of Transforming Growth Factor-{beta} Receptor Type I Is Associated with Invasive Breast Cancer
Clin. Cancer Res., January 15, 2006; 12(2): 392 - 397.
[Abstract] [Full Text] [PDF]


Home page
Recent Prog Horm ResHome page
M. J. McPhaul
Molecular Defects of the Androgen Receptor
Recent Prog. Horm. Res., January 1, 2002; 57(1): 181 - 194.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2000 by The Endocrine Society